摘要
Background: The aim of this study was to evaluate the clinical usefulness of radiomics signature-derived F-18-fluorodeoxyglucose (F-18- FDG) positron emission tomography-computed tomography (PET-CT) for the early prediction of neoadjuvant chemotherapy (NAC) outcomes in patients with (BC). @@@ Methods: A total of 124 patients with BC who underwent pretreatment PET-CT scanning and received NAC between December 2016 and August 2019 were studied. The dataset was randomly assigned in a 7:3 ratio to either the training or validation cohort. Primary tumor segmentation was performed, and radiomics signatures were extracted from each PET-derived volume of interest (VOI) and CT-derived VOI. Radiomics signatures associated with pathological treatment response were selected from within a training cohort (n = 85), which were then applied to generate different classifiers to predict the probability of pathological complete response (pCR). Different models were then independently tested in the validation cohort (n = 39) regarding their accuracy, sensitivity, specificity, and area under the curve (AUC). @@@ Results: Thirty-five patients (28.2%) had pCR to NAC. Twelve features consisting of five PET-derived signatures, four CT-derived signatures, and three clinicopathological variables were candidates for the model's development. The random forest (RF), k-nearest neighbors (KNN), and decision tree (DT) classifiers were established, which could be utilized to predict pCR to NAC with AUC ranging from 0.819 to 0.849 in the validation cohort. @@@ Conclusions: The PET/CT-based radiomics analysis might provide efficient predictors of pCR in patients with BC, which could potentially be applied in clinical practice for individualized treatment strategy formulation.
学科与关键词
- Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CTHuang, Xiaomei; Mai, Jinhai; Huang, Yanqi; He, Lan; Chen, Xin; Wu, Xiaomei; Li, Yexing; Yang, Xiaojun; Dong, Mengyi; Huang, Jia; Zhang, Fang; Liang, Changhong*; Liu, Zaiyi*Clinical Breast Cancer, 2021, 21(4): E388-E401.被引 9
- 18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancerZheng, Xingxing; Huang, Yuhong; Lin, Yingyi; Zhu, Teng; Zou, Jiachen; Wang, Shuxia*; Wang, Kun*EJNMMI Research, 2023, 13(1): 105.
- Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast CancerZeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
